BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1432 related articles for article (PubMed ID: 29130504)

  • 21. New Therapeutic Drugs from Bioactive Natural Molecules: The Role of Gut Microbiota Metabolism in Neurodegenerative Diseases.
    Di Meo F; Donato S; Di Pardo A; Maglione V; Filosa S; Crispi S
    Curr Drug Metab; 2018; 19(6):478-489. PubMed ID: 29623833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbiota compositional profile and serum metabolic phenotype in patients with primary open-angle glaucoma.
    Gong H; Zhang S; Li Q; Zuo C; Gao X; Zheng B; Lin M
    Exp Eye Res; 2020 Feb; 191():107921. PubMed ID: 31917963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Untargeted Soil Metabolomics Using Liquid Chromatography-Mass Spectrometry and Gas Chromatography-Mass Spectrometry.
    Swenson TL; Northen TR
    Methods Mol Biol; 2019; 1859():97-109. PubMed ID: 30421224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolomics in degenerative brain diseases.
    Quintero ME; Pontes JGM; Tasic L
    Brain Res; 2021 Dec; 1773():147704. PubMed ID: 34744014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the adverse impacts of aflatoxin B
    Zhou J; Tang L; Wang JS
    Chemosphere; 2019 Feb; 217():618-628. PubMed ID: 30447610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrative analysis of microbiome and metabolome reveals the linkage between gut microbiota and carp growth.
    Nie Z; Xu X; Shao N; He J; Li P; Xu P; Hu J; Qin W; Wang B; Xu G
    Environ Res; 2023 Mar; 220():115133. PubMed ID: 36563984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
    Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
    Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut-Brain Axis and Neurodegeneration: State-of-the-Art of Meta-Omics Sciences for Microbiota Characterization.
    Tilocca B; Pieroni L; Soggiu A; Britti D; Bonizzi L; Roncada P; Greco V
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated study of metabolomics and gut metabolic activity from ulcerative colitis to colorectal cancer: The combined action of disordered gut microbiota and linoleic acid metabolic pathway might fuel cancer.
    Tang Q; Cang S; Jiao J; Rong W; Xu H; Bi K; Li Q; Liu R
    J Chromatogr A; 2020 Oct; 1629():461503. PubMed ID: 32858455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut metabolome meets microbiome: A methodological perspective to understand the relationship between host and microbe.
    Lamichhane S; Sen P; Dickens AM; Orešič M; Bertram HC
    Methods; 2018 Oct; 149():3-12. PubMed ID: 29715508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases.
    Gubert C; Kong G; Renoir T; Hannan AJ
    Neurobiol Dis; 2020 Feb; 134():104621. PubMed ID: 31628992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic analysis of Panax notoginseng saponins with gut microbiota-mediated biotransformation by HPLC-DAD-Q-TOF-MS/MS.
    Chen MY; Shao L; Zhang W; Wang CZ; Zhou HH; Huang WH; Yuan CS
    J Pharm Biomed Anal; 2018 Feb; 150():199-207. PubMed ID: 29245089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategy for Comprehensive Detection and Annotation of Gut Microbiota-Related Metabolites Based on Liquid Chromatography-High-Resolution Mass Spectrometry.
    Zheng S; Qin W; Chen T; Ouyang R; Wang X; Li Q; Zhao Y; Liu X; Wang D; Zhou L; Xu G
    Anal Chem; 2024 Feb; 96(5):2206-2216. PubMed ID: 38253323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of bowel preparation on the human gut microbiome and metabolome.
    Nagata N; Tohya M; Fukuda S; Suda W; Nishijima S; Takeuchi F; Ohsugi M; Tsujimoto T; Nakamura T; Shimomura A; Yanagisawa N; Hisada Y; Watanabe K; Imbe K; Akiyama J; Mizokami M; Miyoshi-Akiyama T; Uemura N; Hattori M
    Sci Rep; 2019 Mar; 9(1):4042. PubMed ID: 30858400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variations in gut microbiota and fecal metabolic phenotype associated with Fenbendazole and Ivermectin Tablets by 16S rRNA gene sequencing and LC/MS-based metabolomics in Amur tiger.
    He F; Zhai J; Zhang L; Liu D; Ma Y; Rong K; Xu Y; Ma J
    Biochem Biophys Res Commun; 2018 May; 499(3):447-453. PubMed ID: 29596832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice.
    Marcobal A; Kashyap PC; Nelson TA; Aronov PA; Donia MS; Spormann A; Fischbach MA; Sonnenburg JL
    ISME J; 2013 Oct; 7(10):1933-43. PubMed ID: 23739052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome.
    Xu W; Chen D; Wang N; Zhang T; Zhou R; Huan T; Lu Y; Su X; Xie Q; Li L; Li L
    Anal Chem; 2015 Jan; 87(2):829-36. PubMed ID: 25486321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomics of neurodegenerative diseases.
    Botas A; Campbell HM; Han X; Maletic-Savatic M
    Int Rev Neurobiol; 2015; 122():53-80. PubMed ID: 26358890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbiota in neurodegenerative disorders.
    Roy Sarkar S; Banerjee S
    J Neuroimmunol; 2019 Mar; 328():98-104. PubMed ID: 30658292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut Microbiota and its Metabolites: Bridge of Dietary Nutrients and Alzheimer's Disease.
    Zhu G; Zhao J; Zhang H; Wang G; Chen W
    Adv Nutr; 2023 Jul; 14(4):819-839. PubMed ID: 37075947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 72.